Orion S.A. (OEC) Guidance & Earnings Results

On 2026-08-05 Orion S.A. reaffirmed guidance: "FY2026 Adjusted EBITDA guidance reaffirmed at $170-210M; FY2026 free cash flow guidance raised to -$10M to +$20M (from prior -$53M midpoint); FY2026 capex…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OECOrion S.A.Follow OEC — free

Specialty Chemicals · Basic Materials

—

Price chart with a free account

Market cap: 308.0M
P/E TTM: —
Dividend yield: 1.5%
52-week: —
Next earnings: 4 Nov, in 11 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
5 Aug 26	Reaffirmed	FY2026 Adjusted EBITDA guidance reaffirmed at $170-210M; FY2026 free cash flow guidance raised to -$10M to +$20M (from prior -$53M midpoint); FY2026 capex ~$90M. · full year
6 May 26	Raised	FY2026 Adjusted EBITDA guidance raised to $170-210 million from $160-200 million. · full year
17 Feb 26	Lowered	Reducing growth capex; cost rationalization; debt reduction focus
14 Oct 25	Lowered	FY2025 adjusted EBITDA guidance cut to $220-235M from prior range · full year
6 Aug 25	Lowered	FY2025 adjusted EBITDA lowered to $260-290M from $280-320M; free cash flow >$50M maintained · full year

Orion S.A. — questions

What guidance did Orion S.A. give?: On 2026-08-05: "FY2026 Adjusted EBITDA guidance reaffirmed at $170-210M; FY2026 free cash flow guidance raised to -$10M to +$20M (from prior -$53M midpoint); FY2026 capex ~$90M."
When does Orion S.A. report earnings?: Orion S.A.'s next earnings report is expected on 2026-11-04.

Every figure on this page comes from Orion S.A.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.